ALFA Filings
Every announcement, straight from the exchange
Every Senores Pharmaceuticals annual general meeting announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Senores Pharmaceuticals Limited has issued a Postal Ballot Notice seeking shareholder approval for the re-appointment of its Managing Director and Whole Time Director. The e-voting period concludes on November 17, 2026.
Senores Pharmaceuticals held its 9th Annual General Meeting on September 25, 2026. Shareholders approved financial statements, director appointments, and the new Employee Stock Option Scheme 2026.
Senores Pharmaceuticals Ltd submitted its Annual Report for FY 2025-26 and notice for its 9th Annual General Meeting scheduled for September 25, 2026.
Senores Pharmaceuticals Ltd informed the exchange that shareholders approved ordinary and special resolutions via postal ballot, including related party transactions and loan limit enhancements.
Senores Pharmaceuticals has issued a Postal Ballot Notice to shareholders for approval of related party transactions. Voting concludes August 3, 2026, with results announced by August 5.